U.S. aid freeze disrupts HIV treatment programs raising concerns for millions at risk

A recent freeze on U.S. foreign aid has disrupted HIV treatment programs, raising concerns about a potential resurgence of AIDS-related deaths. Millions who rely on medications are now at risk of losing access to life-saving drugs. The halt in funding has led to layoffs of health workers in countries like Kenya and Ethiopia, creating gaps in HIV testing and care. Experts warn that without treatment, HIV can quickly rebound, leading to immune system collapse and increased vulnerability to diseases. The U.N. AIDS agency has begun tracking new infections since the aid freeze. If the situation does not improve, millions could face severe health consequences, including the emergence of drug-resistant strains of HIV.